Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (56)
- Committees and advisory bodies (45)
- Safety monitoring and information (12)
- Advertising (9)
- Manufacturing (9)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Clinical trials (3)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
247 result(s) found, displaying 76 to 100
-
Corporate reportsPrescription opioid tracking research
-
Corporate reportsMedicines Safety Update - Information for health professionals
-
Corporate reportsThe 2020-21 TGA Regulator Performance Framework Self-assessment (KPI) Report has now been published
-
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACMS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 Joint ACMS-ACCS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACCS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 Joint ACMS-ACCS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACMS meeting
-
Corporate reportsPublication of the independent expert review of MDMA and psilocybin.
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in March 2021
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in March 2021
-
Corporate reportsThe Freedom of Information disclosure log gives access to information we've released in response to an FOI request.
-
Corporate reportsWe thank respondents who provided a submission in response to the public consultation paper proposed refinements to the regulation of personalised medical devices.
-
Corporate reportsThe TGA 2020-21 Annual Performance Statistics Report has now been published.
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - March 2021 ACMS/ACCS meetings
-
Corporate reportsIn the past 12-18 months, the TGA has implemented a number of changes in an effort to increase and improve post-market monitoring and surveillance activities.
-
Corporate reportsThe guidelines set out the criteria which must be met for any additional manufacturing sites to be included as secondary sites on new or existing manufacturing licences.
-
Corporate reports2020/21 Therapeutic Goods Advertising Compliance Annual Report has been published
-
Corporate reportsSubmissions published and summarised as part of a consultation on clarifying the regulation of 'residual activity' claims for disinfectants.
-
Corporate reportsThis document contains practical information produced by a team from the University of Wollongong, based on their years of practical research on nicotine vaping products.
-
Corporate reportsPractical flowcharts produced by the University of Wollongong based on their years of practical research on nicotine vaping products
-
Corporate reportsOutcomes following review of consultation submissions
-
Corporate reportsICMRA brings together the heads of over 40 medicines regulatory authorities, with the WHO as an observer.
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.